Biopharmaceutical firm MethylGene Q1 loss down to $2.8M, revenue up to $1.9M

MONTREAL (CP) - MethylGene Inc. cut its first-quarter loss to $2.8 million from a year-ago $3 million as revenues from its licence deals moved upwards, the maker

The loss amounted to 13 cents per diluted share, down from a loss of 18 cents per share in the year-earlier period....More